2-acetylaminofluorene has been researched along with Cardiovascular Diseases in 1 studies
2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lindholm, L | 1 |
| Bryngelsson, T | 1 |
| Pero, R | 1 |
1 other study available for 2-acetylaminofluorene and Cardiovascular Diseases
| Article | Year |
|---|---|
Hypertension, age, and smoking related to genotoxic sensitivity in human lymphocytes: a population study.
Topics: 2-Acetylaminofluorene; Aged; Aging; Blood Pressure; Cardiovascular Diseases; DNA; Humans; Hypertensi | 1986 |